Neurocognitive Assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project Schizophrenia Trial: Development, Methodology, and Rationale
Year: 2003
Type: article
Study design: Study Protocol
Source: Schizophrenia Bulletin
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: schizophrenia, neuropsychological assessment
Open Access status: closed
Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Yale University, University of Southern California, Vanderbilt University, University of Rochester, Otsuka Pharmaceutical, National Institutes of Health, School of Medicine, Vanderbilt University, University of California, Los Angeles, National Institute of Mental Health
OpenAlex ID: W1990247209
